United States · FDA National Drug Code directory

Adrenal Liquescence 3001

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63083-3001_4458191b-2cb9-45a9-a6ce-e9d6033bd480
Product NDC
63083-3001
Form
LIQUID
Composition / generic term
Adrenal Liquescence
Labeler
Professional Complementary Health Formulas
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
19840815
Source listing expiry
20271231

Source-listed ingredients

  • GLYCYRRHIZA GLABRA — 1 [hp_X]/118mL
  • BEE POLLEN — 2 [hp_X]/118mL
  • PAULLINIA CUPANA SEED — 3 [hp_X]/118mL
  • ROSA CANINA FRUIT — 3 [hp_X]/118mL
  • ASIAN GINSENG — 3 [hp_X]/118mL
  • SUS SCROFA ADRENAL GLAND — 6 [hp_X]/118mL
  • CORTICOTROPIN — 6 [hp_X]/118mL
  • EPHEDRA DISTACHYA FLOWERING TWIG — 6 [hp_X]/118mL
  • ZINC — 6 [hp_X]/118mL
  • EPINEPHRINE — 12 [hp_X]/118mL
  • SODIUM CHLORIDE — 12 [hp_X]/118mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 118 mL in 1 BOTTLE, DROPPER (63083-3001-4) · 63083-3001-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Adrenal Liquescence 3001 — United States | Molindra Medicines